UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 3187: Pediatric Preclinical Testing Consortium evaluation of the menin inhibitor, VTP-50469, against xenograft models of MLL-rearranged infant acute lymphoblastic leukemia

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3187-3187

2018

Volltextzugriff (PDF)

The potent, selective RORγt blocker, VTP-43742, suppresses Th17 production in vivo and provides greater benefit than IL-17 blockade in the EAE model of autoimmunity (THER3P.968)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.68-68.1

2015

Volltextzugriff (PDF)

Abstract 334: The LXRβ Selective Agonist, VTP-38443, Significantly Decreases Plaque Cholesterol Ester Content and Inflammation in a Murine Model of Accelerated Atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2015-05, Vol.35 (suppl_1)

2015

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742, a RORγt inhibitor, in normal healthy volunteers

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.71-71.4

2016

Volltextzugriff (PDF)

Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective Iks-blocking class III antiarrhythmic agents

Bioorganic & medicinal chemistry letters, 2003-03, Vol.13 (6), p.1165-1168

2003

Volltextzugriff (PDF)

In Vivo Canine Cardiac Electrophysiologic Profile of 1,4-Benzodiazepine Iks Blockers

Journal of cardiovascular pharmacology, 2003-07, Vol.42 (1), p.105-112

2003

Volltextzugriff (PDF)

VTP-43742 is a potent and selective RORγt blocker that demonstrates oral efficacy in a mouse model of autoimmunity through suppression of IL-17A production (THER7P.945)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.208-208.5|68.3

2015

Volltextzugriff (PDF)

Organolithium addition to aldehyde dimethylhydrazones: a highly diastereocontrolled synthesis of threo 2-amino alcohols, and (1R,2R)-(-)-norpseudoephedrine

Journal of the American Chemical Society, 1986-12, Vol.108 (26), p.8265-8266

1986

Volltextzugriff (PDF)

Spirocyclic ureas: Orally bioavailable 11b-HSD1 inhibitors identified by computer-aided drug design

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.881-886

2010

Volltextzugriff (PDF)

4-Oxospiro[benzopyran-2,4'-piperidines] as class III antiarrhythmic agents. Pharmacological studies on 3,4-dihydro-1'-[2-(benzofurazan-5-yl)ethyl]-6-methanesulfonamidospiro[(2H)-1-benzopyran-2,4'-piperidin]-4-one (L-691,121)

Journal of medicinal chemistry, 1992-10, Vol.35 (21), p.3973-3976

1992

Volltextzugriff (PDF)

Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11-dicarboxylates as calcium entry antagonists: new conformationally restrained analogs of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformation

Journal of medicinal chemistry, 1987-04, Vol.30 (4), p.690-695

1987

Volltextzugriff (PDF)

Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I(Ks), in canine models of malignant ischemic ventricular arrhythmia

Circulation (New York, N.Y.), 1999-11, Vol.100 (18), p.1917-1922

1999

Volltextzugriff (PDF)

Synthesis of 4,5-dihydroazepine-3,6-dicarboxylate derivatives by stereoselective ring expansion-nucleophilic addition to 4-.alpha.-chloroalkyl-1,4-dihydropyridine-3,5-dicarboxylates

Journal of organic chemistry, 1984-10, Vol.49 (20), p.3871-3874

1984

Volltextzugriff (PDF)

Corrigendum to ‘Novel 5-Cyclopropyl-1,4-benzodiazepine-2-ones as Potent and Selective IKs-Blocking Class III Antiarrhythmic Agents’

Bioorganic & medicinal chemistry letters, 2003-08, Vol.13 (15), p.2611

2003

Volltextzugriff (PDF)

Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockade

The Journal of pharmacology and experimental therapeutics, 2002-07, Vol.302 (1), p.283

2002

Volltextzugriff (PDF)

Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective I(Ks)-blocking class III antiarrhythmic agents

Bioorganic & medicinal chemistry letters, 2003-03, Vol.13 (6), p.1165-1168

2003

Volltextzugriff (PDF)

Corrigendum to ‘Novel 5-Cyclopropyl-1,4-benzodiazepine-2-ones as Potent and Selective I Ks-Blocking Class III Antiarrhythmic Agents’ : [Bioorg. Med. Chem. Lett. 13 (2003) 1165]

Bioorganic & medicinal chemistry letters, 2003, Vol.13 (15), p.2611-2611

2003

Volltextzugriff (PDF)

An efficient chemoselective synthesis of nitriles from primary amides

Tetrahedron letters, 1988, Vol.29 (18), p.2155-2158

1988

Volltextzugriff (PDF)

Preparation of 3-amino-1,4-benzodiazepin-2-ones via direct azidation with trisyl azide

Tetrahedron letters, 1996-09, Vol.37 (37), p.6685-6688

1996

Volltextzugriff (PDF)

Chapter 11 - Structure-based Design Technology CONTOUR and its Application to Drug Discovery

Innovations in Biomolecular Modeling and Simulations: Volume 2, 2012, Vol.2, p.265-280

2012

Volltextzugriff (PDF)

Non-peptide fibrinogen receptor antagonists. 21. The synthesis of [3H]L-738,167

Journal of labelled compounds & radiopharmaceuticals, 1998-04, Vol.41 (4), p.273-277

1998

Volltextzugriff (PDF)

Preparation of 7-Alkyl-2,3,6,7-tetrahydro-4-alkyl-2-oxo- 1 H -1,3-diazepine-5-carboxylates by Ring Expansion-Nucleophilic Addition

Synthesis (Stuttgart), 1986, Vol.1986 (8), p.664-665

1986

Volltextzugriff (PDF)

Preparation of 5-Substituted 2-Mercapto-1-methylimidazoles. Direct Metalation of 2-Mercapto-1-methylimidazole

Synthesis (Stuttgart), 1990, Vol.1990 (9), p.761-763

1990

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(33)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 3187: Pediatric Preclinical Testing Consortium evaluation of the menin inhibitor, VTP-50469, against xenograft models of MLL-rearranged infant acute lymphoblastic leukemia

Process Development of the BACE Inhibitors BI 1147560 BS and BI 1181181 MZ

The potent, selective RORγt blocker, VTP-43742, suppresses Th17 production in vivo and provides greater benefit than IL-17 blockade in the EAE model of autoimmunity (THER3P.968)

Abstract 334: The LXRβ Selective Agonist, VTP-38443, Significantly Decreases Plaque Cholesterol Ester Content and Inflammation in a Murine Model of Accelerated Atherosclerosis

Safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742, a RORγt inhibitor, in normal healthy volunteers

Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective Iks-blocking class III antiarrhythmic agents

In Vivo Canine Cardiac Electrophysiologic Profile of 1,4-Benzodiazepine Iks Blockers

VTP-43742 is a potent and selective RORγt blocker that demonstrates oral efficacy in a mouse model of autoimmunity through suppression of IL-17A production (THER7P.945)

Organolithium addition to aldehyde dimethylhydrazones: a highly diastereocontrolled synthesis of threo 2-amino alcohols, and (1R,2R)-(-)-norpseudoephedrine

Spirocyclic ureas: Orally bioavailable 11b-HSD1 inhibitors identified by computer-aided drug design

4-Oxospiro[benzopyran-2,4'-piperidines] as class III antiarrhythmic agents. Pharmacological studies on 3,4-dihydro-1'-[2-(benzofurazan-5-yl)ethyl]-6-methanesulfonamidospiro[(2H)-1-benzopyran-2,4'-piperidin]-4-one (L-691,121)

Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11-dicarboxylates as calcium entry antagonists: new conformationally restrained analogs of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformation

Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I(Ks), in canine models of malignant ischemic ventricular arrhythmia

Class III Antiarrhythmic Activity in Vivo by Selective Blockade of the Slowly Activating Cardiac Delayed Rectifier Potassium Current IKs by (R)-2-(2,4- Trifluoromethyl)-N-[2-oxo-5-phenyl- 1-(2,2,2-trifluoroethyl)-2,3-dihydro- 1H-benzo[e][1,4]diazepin-3-yl]acetamide

Synthesis of 4,5-dihydroazepine-3,6-dicarboxylate derivatives by stereoselective ring expansion-nucleophilic addition to 4-.alpha.-chloroalkyl-1,4-dihydropyridine-3,5-dicarboxylates

Corrigendum to ‘Novel 5-Cyclopropyl-1,4-benzodiazepine-2-ones as Potent and Selective IKs-Blocking Class III Antiarrhythmic Agents’

Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockade

Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective I(Ks)-blocking class III antiarrhythmic agents

Corrigendum to ‘Novel 5-Cyclopropyl-1,4-benzodiazepine-2-ones as Potent and Selective I Ks-Blocking Class III Antiarrhythmic Agents’ : [Bioorg. Med. Chem. Lett. 13 (2003) 1165]

An efficient chemoselective synthesis of nitriles from primary amides

Preparation of 3-amino-1,4-benzodiazepin-2-ones via direct azidation with trisyl azide

Chapter 11 - Structure-based Design Technology CONTOUR and its Application to Drug Discovery

Non-peptide fibrinogen receptor antagonists. 21. The synthesis of [3H]L-738,167

Preparation of 7-Alkyl-2,3,6,7-tetrahydro-4-alkyl-2-oxo- 1 H -1,3-diazepine-5-carboxylates by Ring Expansion-Nucleophilic Addition

Preparation of 5-Substituted 2-Mercapto-1-methylimidazoles. Direct Metalation of 2-Mercapto-1-methylimidazole

Aktive Filter

Suchergebnisse filtern